Gapping down
In reaction to earnings/guidance:
- SMG -13.1% (lowered guidance), OLLI -7.2%, SMAR -6.4%, CS -5.6% (Trading update), LOVE -3.2%, OI -2.7%, GWRE -2.1%, CASY -2.1% (also increases dividend)
Other news:
- RIGL -60.2% (Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib)
- CDRE -4.6% (stock offering)
- TER -2.8% (names Greg Smith as president)
- WTFC -2.7% (prices offering of 3.0 mln shares of common stock at $86.00 per share)
- EURN -2.7% (INSW completes transaction to sell 50% stake in FSO vessels to EURN)
- TALS -2.1% (presents additional Phase 2 data and analyses)
- CCSI -2% (files for 2 mln share offering by selling shareholders)
Analyst comments:
- CGC -4.2% (downgraded to Underperform from Market Perform at BMO Capital Markets)
- MO -2.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- BROS -2.2% (downgraded to Neutral from Overweight at JP Morgan)
- TGT -1.1% (downgraded to Neutral from Buy at BofA Securities)